MX9708018A - Factor de crecimiento transformante alfa hii. - Google Patents
Factor de crecimiento transformante alfa hii.Info
- Publication number
- MX9708018A MX9708018A MX9708018A MX9708018A MX9708018A MX 9708018 A MX9708018 A MX 9708018A MX 9708018 A MX9708018 A MX 9708018A MX 9708018 A MX9708018 A MX 9708018A MX 9708018 A MX9708018 A MX 9708018A
- Authority
- MX
- Mexico
- Prior art keywords
- polypeptides
- growth factor
- present
- transforming growth
- factor alpha
- Prior art date
Links
- NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 title abstract 2
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 title abstract 2
- 101800004564 Transforming growth factor alpha Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000022873 Ocular disease Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000013020 embryo development Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion describe polipéptidos de factor de crecimiento transformante alfa HII y polinucleotidos que codifican para metales polipéptidos. También se proporciona un procedimiento para producir tales polipéptidos mediante técnicas recombinantes y usos terapéuticos de los polipéptidos los cuales incluyen estimulacion de sanado de heridas, tratamiento de trastornos neurologicos, tratamiento de trastornos oculares, tratamiento de trastornos renales y hepáticos y estimulacion de la embriogénesis y angiogénesis. También se describen antagonistas contra tales polipéptidos y su uso como una sustancia terapéutica para tratar neoplasias. También se describen ensayos diagnosticos para detectar niveles alterados del polipéptido de la presente invencion y mutaciones en las secuencias de ácido nucleico las cuales codifican para los polipéptidos de la presente invencion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1995/006386 WO1996036709A1 (en) | 1995-05-19 | 1995-05-19 | Transforming growth factor alpha hii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9708018A true MX9708018A (es) | 1997-11-29 |
Family
ID=39164708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9708018A MX9708018A (es) | 1995-05-19 | 1995-05-19 | Factor de crecimiento transformante alfa hii. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX9708018A (es) |
-
1995
- 1995-05-19 MX MX9708018A patent/MX9708018A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2380690A1 (en) | Human osteoclast-derived cathepsin | |
| NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
| EP0787802A3 (es) | ||
| MX9604985A (es) | Cardiotropina y usos de la misma. | |
| WO2001032910A3 (en) | 27 human secreted proteins | |
| WO2001034768A3 (en) | 15 human secreted proteins | |
| WO2001012776A3 (en) | 18 human secreted proteins | |
| WO2000077026A8 (en) | 49 human secreted proteins | |
| EP0330396A3 (en) | Dna sequences, recombinant dna molecules and processes for producing lipocortins iii, iv, v & vi | |
| AU2642795A (en) | Transforming growth factor alpha hii | |
| EP0856050A4 (en) | TRANSFORMING GROWTH FACTOR ALPHA HI | |
| WO2000063230A3 (en) | 49 human secreted proteins | |
| EP0587571A4 (en) | HUMAN GALANINE, cDNA CLONES ENCODING HUMAN GALANINE AND PROCESS FOR PRODUCING HUMAN GALANINE. | |
| WO2003029423A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
| WO2003022998A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
| WO2000058339A3 (en) | 50 human secreted proteins | |
| WO2001012775A8 (en) | 25 human secreted proteins | |
| WO2003040329A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
| DE69634994D1 (de) | Bindegewebe-wachstumsfaktor 3. | |
| WO2000061624A8 (en) | 48 human secreted proteins | |
| WO2000043495A3 (en) | 33 human secreted proteins | |
| MX9707617A (es) | Factor de crecimiento de criptina humano. | |
| WO2003052377A9 (en) | 41 human secreted proteins | |
| WO2000061596A8 (en) | 50 human secreted proteins | |
| WO2003064589A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |